Reduced activity of CD13/aminopeptidase N (APN) in aggressive meningiomas is associated with increased levels of SPARC

Brain Pathology

Volumn 20, Issue 1, 2010, Pages 200-210

  Mawrin, Christian ^a,b   Wolke, Carmen ^b,d   Haase, Daniela ^a   Krüger, Sabine ^b   Firsching, Raimund ^b   Keilhoff, Gerburg ^b   Paulus, Werner ^c   Gutmann, David H ^e   Lal, Anita ^f   Lendeckel, Uwe ^b,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD13; Invasion; Meningioma

Indexed keywords

ACTINONIN; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; ENZYME ANTIBODY; ENZYME INHIBITOR; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; OSTEONECTIN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; MENINGIOMA; MICROARRAY ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD13; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGIOMA; NEOPLASM INVASIVENESS; OSTEONECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 71549166373     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00267.x     Document Type: Article

References (35)

1. Bhagwat SV, Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro LH (2001) CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97 : 652 659.
2. Bostrom J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P et al (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159 : 661 669. (Pubitemid 32751096)
3. Bradshaw AD, Sage EH 2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107 : 1049 1054.
4. Carl-McGrath S, Lendeckel U, Ebert M, Wolter AB, Roessner A, Rocken C (2004) The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int J Oncol 25 : 1223 1232.
5. Carl-McGrath S, Lendeckel U, Ebert M, Rocken C (2006) Ectopeptidases in tumour biology: a review. Histol Histopathol 21 : 1339 1353.
6. Cuevas IC, Slocum AL, Jun P, Costello JF, Bollen AW, Riggins GJ et al (2005) Meningioma transcript profiles reveal deregulated Notch signaling pathway. Cancer Res 65 : 5070 5075.
7. Dixon J, Kaklamanis L, Turley H, Hickson ID, Leek RD, Harris AL, Gatter KC (1994) Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol 47 : 43 47.
8. Dunn JR, Reed JE, du Plessis DG, Shaw EJ, Reeves P, Gee AL et al (2006) Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer 94 : 1186 1193.
9. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I, Tsuruo T (1995) Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis 13 : 337 344.
10. Hashida H, Takabayashi A, Kanai M, Adachi M, Kondo K, Kohno N et al (2002) Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology 122 : 376 386.
11. Ishii K, Usui S, Sugimura Y, Yoshida S, Hioki T, Tatematsu M et al (2001) Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. Int J Cancer 92 : 49 54.
12. Ishii K, Usui S, Yamamoto H, Sugimura Y, Tatematsu M, Hirano K (2001) Decreases of metallothionein and aminopeptidase N in renal cancer tissues. J Biochem (Tokyo) 129 : 253 258.
13. Kido A, Krueger S, Haeckel C, Roessner A (1999) Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines. Clin Exp Metastasis 17 : 857 863.
14. Kido A, Krueger S, Haeckel C, Roessner A (2003) Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells. Clin Exp Metastasis 20 : 585 592.
15. Kilic T, Bayri Y, Ozduman K, Acar M, Diren S, Kurtkaya O et al (2002) Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery 51 : 183 192.
16. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO Classification of Tumours of the Central Nervous System, 4th edn. IARC Press : Lyon.
17. Mawrin C, Sasse T, Kirches E, Kropf S, Schneider T, Grimm C et al (2005) Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas. Clin Cancer Res 11 : 4074 4082.
18. Mechtersheimer G, Moller P (1990) Expression of aminopeptidase N (CD13) in mesenchymal tumors. Am J Pathol 137 : 1215 1222.
19. Nordqvist AC, Peyrard M, Pettersson H, Mathiesen T, Collins VP, Dumanski JP, Schalling M (1997) A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas. Cancer Res 57 : 2611 2614.
20. Nordqvist AC, Smurawa H, Mathiesen T (2001) Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. J Neurosurg 95 : 839 844.
21. Okada M, Miyake K, Matsumoto Y, Kawai N, Kunishio K, Nagao S (2004) Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. J Neurooncol 66 : 29 37.
22. Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A et al (2000) Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 60 : 722 727.
23. Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70 : 183 202.
24. Puttmann S, Senner V, Braune S, Hillmann B, Exeler R, Rickert CH, Paulus W (2005) Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest 85 : 1163 1171.
25. Rangel R, Sun Y, Guzman-Rojas L, Ozawa MG, Sun J, Giordano RJ et al (2007) Impaired angiogenesis in aminopeptidase N-null mice. Proc Natl Acad Sci USA 104 : 4588 4593.
26. Rempel SA, Ge S, Gutierrez JA 1999) SPARC a potential diagnostic marker of invasive meningiomas. Clin Cancer Res 5 : 237 241.
27. Rocken C, Carl-McGrath S, Grantzdorffer I, Mantke R, Roessner A, Lendeckel U (2004) Ectopeptidases are differentially expressed in hepatocellular carcinomas. Int J Oncol 24 : 487 495.
28. Rocken C, Licht J, Roessner A, Carl-McGrath S (2005) Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma. J Clin Pathol 58 : 1069 1075.
29. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, Azuma I (1993) Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 54 : 137 143.
30. Schittenhelm J, Mittelbronn M, Roser F, Tatagiba M, Mawrin C, Bornemann A (2006) Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas. Neuropathol Appl Neurobiol 32 : 525 531.
31. Surace EI, Lusis E, Murakami Y, Scheithauer BW, Perry A, Gutmann DH (2004) Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. J Neuropathol Exp Neurol 63 : 1015 1027.
32. van Hensbergen Y, Broxterman HJ, Rana S, van Diest PJ, Duyndam MC, Hoekman K et al (2004) Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts. Clin Cancer Res 10 : 1180 1191.
33. Vazquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M, Iruela-Arispe ML (1999) METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 274 : 23349 23357.
34. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94 : 14719 14724.
35. Zeltner L, Schittenhelm J, Mittelbronn M, Roser F, Tatagiba M, Mawrin C et al (2007) The astrocytic response towards invasive meningiomas. Neuropathol Appl Neurobiol 33 : 163 168.